+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Insulin Delivery System Market Research Report by Product Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4905037
  • Report
  • July 2021
  • Region: Global
  • 186 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Insulin Delivery System Market will Grow to USD 20.87 Billion by 2026, at a CAGR of 7.68%

FEATURED COMPANIES

  • Biocon Limited
  • Eli Lilly and Company
  • Insulet Corporation
  • Medtronic PLC
  • Novo Nordisk A/S
  • Sanofi
  • MORE
The Global Insulin Delivery System Market size was estimated at USD 13.38 Billion in 2020 and expected to reach USD 14.37 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 7.68% to reach USD 20.87 Billion by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Insulin Delivery System to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product Type, the Insulin Delivery System Market was examined across Insulin Jet Injectors, Insulin Pens, Insulin Pumps, and Syringes.
  • Based on End User, the Insulin Delivery System Market was examined across Hospitals, Retail channels, and Specialty Diabetic Clinics.
  • Based on Geography, the Insulin Delivery System Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Insulin Delivery System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Insulin Delivery System Market, including Animas Corporation (Johnson and Johnson), Becton, Dickinson and Company, Biocon Limited, Eli Lilly and Company, Insulet Corporation, Medtronic PLC, Novo Nordisk A/S, Sanofi, Tandem Diabetes Care, Inc., and Ypsomed Holding AG.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Insulin Delivery System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Insulin Delivery System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Insulin Delivery System Market?
4. What is the competitive strategic window for opportunities in the Global Insulin Delivery System Market?
5. What are the technology trends and regulatory frameworks in the Global Insulin Delivery System Market?
6. What is the market share of the leading vendors in the Global Insulin Delivery System Market?
7. What modes and strategic moves are considered suitable for entering the Global Insulin Delivery System Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biocon Limited
  • Eli Lilly and Company
  • Insulet Corporation
  • Medtronic PLC
  • Novo Nordisk A/S
  • Sanofi
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Type Outlook
3.4. End User Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing chronic diseases and adoption of advanced devices for insulin delivery
5.1.1.2. Increasing diabetic population & obese population
5.1.1.3. Technological advancements in insulin delivery systems
5.1.2. Restraints
5.1.2.1. Technological advancements in insulin delivery systems
5.1.3. Opportunities
5.1.3.1. Rising consumer awareness about the latest insulin delivery devices
5.1.3.2. Collaboration of public and private sectors to meet diabetes needs
5.1.3.3. Technological advancements and rising product launches
5.1.4. Challenges
5.1.4.1. Stringent government rules and regulations governing the product approval process
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Insulin Delivery System Market, by Product Type
6.1. Introduction
6.2. Insulin Jet Injectors
6.3. Insulin Pens
6.4. Insulin Pumps
6.5. Syringes

7. Insulin Delivery System Market, by End User
7.1. Introduction
7.2. Hospitals
7.3. Retail channels
7.4. Specialty Diabetic Clinics

8. Americas Insulin Delivery System Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Insulin Delivery System Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand

10. Europe, Middle East & Africa Insulin Delivery System Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Animas Corporation (Johnson and Johnson)
12.2. Becton, Dickinson and Company
12.3. Biocon Limited
12.4. Eli Lilly and Company
12.5. Insulet Corporation
12.6. Medtronic PLC
12.7. Novo Nordisk A/S
12.8. Sanofi
12.9. Tandem Diabetes Care, Inc.
12.10. Ypsomed Holding AG

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2020 (USD BILLION)
FIGURE 3. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2020 (USD BILLION)
FIGURE 4. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
FIGURE 5. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 6. GLOBAL INSULIN DELIVERY SYSTEM MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL INSULIN DELIVERY SYSTEM MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2026 (%)
FIGURE 9. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2026
FIGURE 11. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN JET INJECTORS, 2018-2026 (USD BILLION)
FIGURE 12. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN JET INJECTORS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 13. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN PENS, 2018-2026 (USD BILLION)
FIGURE 14. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN PENS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 15. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2026 (USD BILLION)
FIGURE 16. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 17. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY SYRINGES, 2018-2026 (USD BILLION)
FIGURE 18. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY SYRINGES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 19. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 20. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2020 VS 2026 (USD BILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2026
FIGURE 22. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2026 (USD BILLION)
FIGURE 23. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 24. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL CHANNELS, 2018-2026 (USD BILLION)
FIGURE 25. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL CHANNELS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 26. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY SPECIALTY DIABETIC CLINICS, 2018-2026 (USD BILLION)
FIGURE 27. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY SPECIALTY DIABETIC CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 28. AMERICAS INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 29. AMERICAS INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 31. ARGENTINA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 32. BRAZIL INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 33. CANADA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 34. MEXICO INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 35. UNITED STATES INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 36. ASIA-PACIFIC INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 37. ASIA-PACIFIC INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 39. AUSTRALIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 40. CHINA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 41. INDIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 42. INDONESIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 43. JAPAN INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 44. MALAYSIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 45. PHILIPPINES INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 46. SINGAPORE INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 47. SOUTH KOREA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 48. THAILAND INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 49. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 50. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 52. FRANCE INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 53. GERMANY INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 54. ITALY INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 55. NETHERLANDS INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 56. QATAR INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 57. RUSSIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 58. SAUDI ARABIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 59. SOUTH AFRICA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 60. SPAIN INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 61. UNITED ARAB EMIRATES INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 62. UNITED KINGDOM INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 63. GLOBAL INSULIN DELIVERY SYSTEM MARKET: FPNV POSITIONING MATRIX
FIGURE 64. GLOBAL INSULIN DELIVERY SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 65. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INSULIN DELIVERY SYSTEM MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL INSULIN DELIVERY SYSTEM MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN JET INJECTORS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN PENS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY SYRINGES, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL CHANNELS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY SPECIALTY DIABETIC CLINICS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 13. AMERICAS INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 14. AMERICAS INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 15. AMERICAS INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 16. ARGENTINA INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 17. ARGENTINA INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 18. BRAZIL INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 19. BRAZIL INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 20. CANADA INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 21. CANADA INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 22. MEXICO INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 23. MEXICO INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 24. UNITED STATES INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 25. UNITED STATES INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 26. UNITED STATES INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 27. ASIA-PACIFIC INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 28. ASIA-PACIFIC INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 29. ASIA-PACIFIC INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 30. AUSTRALIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 31. AUSTRALIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 32. CHINA INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 33. CHINA INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 34. INDIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 35. INDIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 36. INDONESIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 37. INDONESIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 38. JAPAN INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 39. JAPAN INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 40. MALAYSIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 41. MALAYSIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 42. PHILIPPINES INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 43. PHILIPPINES INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 44. SINGAPORE INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 45. SINGAPORE INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 46. SOUTH KOREA INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 47. SOUTH KOREA INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 48. THAILAND INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 49. THAILAND INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 53. FRANCE INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 54. FRANCE INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 55. GERMANY INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 56. GERMANY INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 57. ITALY INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 58. ITALY INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 59. NETHERLANDS INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 60. NETHERLANDS INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 61. QATAR INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 62. QATAR INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 63. RUSSIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 64. RUSSIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 65. SAUDI ARABIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 66. SAUDI ARABIA INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 67. SOUTH AFRICA INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 68. SOUTH AFRICA INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 69. SPAIN INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 70. SPAIN INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 71. UNITED ARAB EMIRATES INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 72. UNITED ARAB EMIRATES INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 73. UNITED KINGDOM INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 74. UNITED KINGDOM INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 75. GLOBAL INSULIN DELIVERY SYSTEM MARKET: SCORES
TABLE 76. GLOBAL INSULIN DELIVERY SYSTEM MARKET: BUSINESS STRATEGY
TABLE 77. GLOBAL INSULIN DELIVERY SYSTEM MARKET: PRODUCT SATISFACTION
TABLE 78. GLOBAL INSULIN DELIVERY SYSTEM MARKET: RANKING
TABLE 79. GLOBAL INSULIN DELIVERY SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 80. GLOBAL INSULIN DELIVERY SYSTEM MARKET: MERGER & ACQUISITION
TABLE 81. GLOBAL INSULIN DELIVERY SYSTEM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 82. GLOBAL INSULIN DELIVERY SYSTEM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 83. GLOBAL INSULIN DELIVERY SYSTEM MARKET: INVESTMENT & FUNDING
TABLE 84. GLOBAL INSULIN DELIVERY SYSTEM MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 85. GLOBAL INSULIN DELIVERY SYSTEM MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Animas Corporation (Johnson and Johnson)
  • Becton, Dickinson and Company
  • Biocon Limited
  • Eli Lilly and Company
  • Insulet Corporation
  • Medtronic PLC
  • Novo Nordisk A/S
  • Sanofi
  • Tandem Diabetes Care, Inc.
  • Ypsomed Holding AG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll